Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent
- PMID: 11159747
- DOI: 10.1093/carcin/22.1.99
Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent
Erratum in
- Carcinogenesis 2002 Feb;23(2):373
Abstract
Mutagenic carcinogens rapidly induced tumors in the p53 haploinsufficient mouse. Heterozygous p53-deficient (+/-) mice were exposed to different mutagenic carcinogens to determine whether p53 loss of heterozygosity (LOH) was carcinogen-and tissue-dependent. For 26 weeks, C57BL/6 (N4) [corrected] p53-deficient (+/-) male or female mice were exposed to p-cresidine, benzene or phenolphthalein. Tumors were examined first for loss of the wild-type p53 allele. p-cresidine induced p53 LOH in three of 13 bladder tumors, whereas hepatocellular tumors showed p53 LOH in carcinomas (2/2), but not in adenomas (0/3). Benzene induced p53 LOH in 13 of 16 tumors examined. Finally, phenolphthalein induced p53 LOH in all tumors analyzed (21/21). Analysis of the p-cresidine-induced bladder tumors by cold single-strand conformation polymorphism (SSCP) analysis of exon 4-9 amplicons failed to demonstrate polymorphisms associated with mutations in tumors that retained the p53 wild-type allele. p-cresidine induced a dose-related increase in lacI mutations in bladder DNA. In summary, these data demonstrate that loss of the wild-type allele occurred frequently in thymic lymphomas and sarcomas, but less frequently in carcinomas of the urinary bladder. In the bladder carcinomas other mechanisms may be operational. These might include (i) other mechanisms of p53 inactivation, (ii) inactivating mutations occurring outside exons 4-9 or (iii) p53 haploinsufficiency creating a condition that favors other critical genetic events which drive bladder carcinogenesis, as evidenced by the significant decrease in tumor latency. Understanding the mechanisms of p53 LOH and chemical carcinogenesis in this genetically altered model could lead to better models for prospective identification and understanding of potential human carcinogens and the role of the p53 tumor suppressor gene in different pathways of chemical carcinogenesis.
Similar articles
-
Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice.Carcinogenesis. 2001 Jan;22(1):89-98. doi: 10.1093/carcin/22.1.89. Carcinogenesis. 2001. PMID: 11159746
-
LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.Carcinogenesis. 1999 Apr;20(4):715-8. doi: 10.1093/carcin/20.4.715. Carcinogenesis. 1999. PMID: 10223204
-
Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitors.Int J Cancer. 2017 Mar 15;140(6):1364-1369. doi: 10.1002/ijc.30554. Int J Cancer. 2017. PMID: 28008605
-
The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens.Toxicol Pathol. 2001;29 Suppl:24-9. doi: 10.1080/019262301753178456. Toxicol Pathol. 2001. PMID: 11695559 Review.
-
Is p53 haploinsufficient for tumor suppression? Implications for the p53+/- mouse model in carcinogenicity testing.Toxicol Pathol. 2001;29 Suppl:147-54. doi: 10.1080/019262301753178555. Toxicol Pathol. 2001. PMID: 11695551 Review.
Cited by
-
The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans.Blood. 2012 Dec 20;120(26):5118-27. doi: 10.1182/blood-2012-05-356014. Epub 2012 Sep 27. Blood. 2012. PMID: 23018641 Free PMC article. Review.
-
Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy.Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):E1480-9. doi: 10.1073/pnas.1219142110. Epub 2013 Mar 29. Proc Natl Acad Sci U S A. 2013. PMID: 23542378 Free PMC article.
-
Cis lethal genetic interactions attenuate and alter p53 tumorigenesis.Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5511-5. doi: 10.1073/pnas.1001223107. Epub 2010 Mar 8. Proc Natl Acad Sci U S A. 2010. PMID: 20212136 Free PMC article.
-
p53 Is Not Required for High CIN to Induce Tumor Suppression.Mol Cancer Res. 2021 Jan;19(1):112-123. doi: 10.1158/1541-7786.MCR-20-0488. Epub 2020 Sep 18. Mol Cancer Res. 2021. PMID: 32948674 Free PMC article.
-
Toxicology and carcinogenesis study of senna in C3B6.129F1-Trp53 tm1Brd N12 haploinsufficient mice.Toxicol Pathol. 2013 Jul;41(5):770-8. doi: 10.1177/0192623312464304. Epub 2012 Nov 2. Toxicol Pathol. 2013. PMID: 23125117 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous